Determination of CYP2C19 Polymorphism, Side Effects, and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors

Creative Commons License

Deniz S., SANCAR M., OKUYAN B., ATA P., BİNGÖL ÖZAKPINAR Ö., Talas A., ...Daha Fazla

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.26, sa.2, ss.152-160, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5455/bcp.20151003060610
  • Dergi Adı: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.152-160
  • Anahtar Kelimeler: CYP2C19 polymorphism, side effects, medication adherence, selective serotonin reuptake inhibitors, HUMAN LIVER-MICROSOMES, N-DEMETHYLATION, CYTOCHROME-P450 ENZYMES, ANTIDEPRESSANT TREATMENT, PSYCHIATRIC-PATIENTS, IN-VITRO, SERTRALINE, GENOTYPE, DEPRESSION, CITALOPRAM
  • Marmara Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study is to determine relationship of cytochrome P-450 2C19 (CYP2C19) enzymes polymorphism, side effects, and medication adherence in patients who have been diagnosed with major depression and have utilized selective serotonin reuptake inhibitors.